1. Translating the Latest and Greatest Advances in PAH Into Clinical Practice

3. Program Goals

4. Determinants of Prognosis in PAH

5. Risk Stratification and Assessment

6. COMPERA Registry

7. French Registry

8. French Registry (cont)

9. French Registry: Survival Based on Number of Low-Risk Criteria Achieved at First Evaluation

10. REVEAL: Updated PAH Risk Score

11. REVEAL: Updated PAH Risk Score (cont)

12. Risk Assessment at Baseline Is Important

13. French Registry: BNP Subset Analysis

14. Treatment Considerations

15. More Complex PAH

16. Monotherapy vs Initial Combination Therapy?

17. Role of Monotherapy Today

18. Role of Monotherapy Today (cont)

19. Clinical Follow-Up of Patients With PAH

20. Treatment Follow-Up

21. Follow-Up

22. Thresholds for Escalating Therapy

23. Initial Triple Therapy

24. Concluding Remarks

25. Abbreviations

26. Abbreviations (cont)

27. Abbreviations (cont)